
|Articles|June 1, 2001
The American Journal of Managed Care
- June 2001
- Volume 7
- Issue 6
Effect of Rofecoxib Therapy on Measures of Health-Related Quality of Life in Patients with Osteoarthritis
Advertisement
Articles in this issue
over 24 years ago
Does the HEDIS Asthma Measure Go Far Enough?over 24 years ago
Rheumatoid Arthritis: Guidelines for Emerging TherapiesNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement




























































